PMDA — authorised 25 September 2020
- Marketing authorisation holder: Gilead Sciences
- Status: approved
🇯🇵 Jyseleca in Japan
PMDA authorised Jyseleca on 25 September 2020
Marketing authorisations
PMDA
- Application: Jyseleca
- Local brand name: Jyseleca
- Status: approved
Jyseleca in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in Japan
Frequently asked questions
Is Jyseleca approved in Japan?
Yes. PMDA authorised it on 25 September 2020; PMDA has authorised it.
Who is the marketing authorisation holder for Jyseleca in Japan?
Gilead Sciences holds the Japanese marketing authorisation.